TRYPF
Price:
$0.0562
Market Cap:
$5.79M
Tryp Therapeutics Inc. is a biopharmaceutical company dedicated to identifying and advancing novel therapeutic compounds for medical conditions characterized by significant unmet needs. Its flagship development initiative, known as PFN, focuses on addressing neuropsychiatric disorders by utilizing precisely formulated synthetic psilocybin. Within the PFN framework, specific drug candidates TRP-8802 and TRP-8803 are being developed to potentially treat a range of complex conditions, including fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. To support its research and clinical endeavors, the company collaborates with Calvert Lab...[Read more]
Industry
Biotechnology
IPO Date
2021-02-08
Stock Exchange
OTC
Ticker
TRYPF
According to Tryp Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 402.50%. This represents a change of 1.49% compared to the average of 25.33% of the last 4 quarters.
The mean historical ROE of Tryp Therapeutics Inc. over the last ten years is -187.22%. The current 402.50% ROE has changed -314.99% with respect to the historical average. Over the past ten years (40 quarters), TRYPF's ROE was at its highest in in the November 2022 quarter at 540.98%. The ROE was at its lowest in in the August 2022 quarter at -195.45%.
Average
-187.22%
Median
-116.68%
Minimum
-655.57%
Maximum
140.07%
Discovering the peaks and valleys of Tryp Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 817.33%
Maximum Annual ROE = 140.07%
Minimum Annual Increase = -121.37%
Minimum Annual ROE = -655.57%
| Year | ROE | Change |
|---|---|---|
| 2023 | 140.07% | -121.37% |
| 2022 | -655.57% | 211.54% |
| 2021 | -210.43% | 817.33% |
The current ROE of Tryp Therapeutics Inc. (TRYPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-241.98%
5-year avg
-187.22%
10-year avg
-187.22%
Tryp Therapeutics Inc.’s ROE is less than Intellipharmaceutics International Inc. (27.35%), less than Rhinomed Limited (1.59%), greater than Fire & Flower Holdings Corp. (-97.46%), greater than BerGenBio ASA (-113.42%), greater than Polydex Pharmaceuticals Limited (-53.04%), greater than Qualis Innovations, Inc. (-16.82%), greater than VIVO Cannabis Inc. (-78.09%), greater than Deltex Medical Group plc (-45.48%), greater than Bloom Health Partners Inc. (-17.42%), less than China Infrastructure Construction Corp. (122.64%),
| Company | ROE | Market cap |
|---|---|---|
| 27.35% | $4.96M | |
| 1.59% | $5.45M | |
| -97.46% | $5.42M | |
| -113.42% | $9.49B | |
| -53.04% | $6.82M | |
| -16.82% | $5.45M | |
| -78.09% | $5.67M | |
| -45.48% | $180.58M | |
| -17.42% | $5.22M | |
| 122.64% | $5.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tryp Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tryp Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tryp Therapeutics Inc.'s ROE?
How is the ROE calculated for Tryp Therapeutics Inc. (TRYPF)?
What is the highest ROE for Tryp Therapeutics Inc. (TRYPF)?
What is the 3-year average ROE for Tryp Therapeutics Inc. (TRYPF)?
What is the 5-year average ROE for Tryp Therapeutics Inc. (TRYPF)?
How does the current ROE for Tryp Therapeutics Inc. (TRYPF) compare to its historical average?